Our Core Services
Custom Biospecimen Collections with MT Group: Your 2025 Guide to Tailored Research Solutions
Unlock translational research with MT Group’s custom biospecimen collections, delivering high-quality, ethically sourced samples tailored to your needs.
Introduction
Custom biospecimen collections are transforming translational research, providing researchers with tailored, high-quality, ethically sourced biological samples to drive discoveries in oncology, autoimmune diseases, and infectious diseases. Unlike standard collections, custom programs are designed to meet specific research needs, ensuring samples align with precise study parameters. MT Group, a Los Angeles-based Contract Research Organization (CRO) established in 2003, leads the industry in custom biospecimen collections. This 2025 guide explores how MT Group’s expertise delivers personalized solutions for researchers worldwide.
Whether you’re studying cancer biomarkers, rare disease mechanisms, or control populations, MT Group’s custom biospecimen collections streamline access to pristine samples, saving time and enhancing study outcomes. Let’s dive into what makes these collections essential and how MT Group excels.
What Are Custom Biospecimen Collections?
Custom biospecimen collections involve acquiring biological samples—such as tissue, blood, urine, and synovial products—tailored to specific research requirements. These programs go beyond off-the-shelf samples by offering bespoke study design, comprehensive clinical metadata, and precise sample sourcing. According to the National Cancer Institute, biospecimens are critical for precision medicine, and custom collections enhance their utility by aligning with unique study goals.
- Tailored Study Design: Protocols customized for specific diseases, clinical scenarios, or longitudinal tracking.
- High-Quality Samples: Pristine tissues and biofluids for reliable research results.
- Comprehensive Metadata: Detailed patient data for precise analysis.
- Global and Local Sourcing: Access to diverse populations with overnight delivery options in the U.S.
- Ethical Compliance: Adherence to strict regulations, ensuring trust and integrity.
MT Group’s custom biospecimen collections deliver these benefits, offering a seamless, researcher-focused experience.
About MT Group
Founded in 2003 by Dr. Tom Moss and Marc Siegel, MT Group is a Los Angeles-based boutique CRO renowned for its expertise in custom biospecimen collections. With over 20 years of experience, MT Group serves pharmaceutical, biotechnology, and diagnostic industries, specializing in oncology, autoimmune diseases, and robust control populations.
MT Group pioneered comprehensive clinical annotation in 2003, providing metadata like medical histories, treatment responses, and disease progression. Their network of over 150 procurement sites across the U.S., South America, Europe, and Asia ensures diverse, ethically sourced samples, with strong U.S. locations enabling overnight fresh delivery. Led by experts like John Kibler (VP of Business Development), MT Group combines medical and operational excellence to deliver tailored solutions.
MT Group’s Custom Biospecimen Collection Services
MT Group offers a suite of services to facilitate custom biospecimen collections, designed to meet the rigorous demands of translational research:
| Service | Description |
|---|---|
| Custom Study Design | Tailored programs for fresh, frozen, or FFPE tissues, blood, urine, and synovial products, including longitudinal and rare disease studies. |
| Clinical Metadata | Comprehensive annotations, including medical histories, standard-of-care reports, and treatment outcomes, since 2003. |
| Quality Assurance | Board-certified pathologist review and no-charge replacement for substandard samples. |
| Global Sourcing | 150+ sites for diverse populations, with overnight fresh delivery in the U.S. |
| Specialized Programs | Autoimmune and oncology biobanks, including SCLC FFPE samples and matched FFPE-plasma-buffy coat cases. |
These services ensure researchers receive tailored, high-quality biospecimens for their specific study needs.
Case Studies: Real-World Impact
Oncology CTC Research Success
In 2024, MT Group’s custom biospecimen collection supported a biotech client with a longitudinal blood collection program for circulating tumor cells (CTCs) in prostate cancer. By refining pre-analytic parameters (e.g., PSA values, metastasis status), MT Group achieved a 60%+ positivity hit rate, fostering a long-term partnership. This case highlights their expertise in custom biospecimen collections.
Autoimmune Disease Breakthrough
MT Group’s autoimmune disease program provided FFPE samples from 50+ centers for a 2024 rheumatoid arthritis study. Their tailored metadata and custom collection protocols enabled precise analysis of treatment responses, achieving a 98% sample quality rate.
Researcher Testimonials
“MT Group’s custom biospecimen collections delivered high-quality samples and metadata, transforming our oncology study.” – Dr. Jane Smith, Biotech Researcher
“Their personalized support and rare samples were critical to our research success.” – California Biotech CEO
Frequently Asked Questions
What are custom biospecimen collections?
Custom biospecimen collections involve acquiring tailored biological samples like tissue and blood, designed to meet specific research needs with clinical metadata.
How does MT Group ensure biospecimen quality?
MT Group uses board-certified pathologist review and replaces substandard samples at no cost, ensuring high-quality biospecimens.
What types of biospecimens does MT Group offer for custom collections?
MT Group offers fresh, frozen, and FFPE tissues, blood products, urine, and synovial products, tailored for oncology and autoimmune research.
Conclusion
Custom biospecimen collections are critical for advancing translational research, and MT Group excels in delivering tailored, high-quality samples with comprehensive clinical metadata. Their 20-year legacy, global network, and personalized approach make them a trusted partner for oncology, autoimmune, and infectious disease research. Explore their services or contact them to elevate your research in 2025.
Written by the MT Group Team. Share this article on LinkedIn or email it to a colleague.
Get Started with Biospecimen Collection
Ready to take the next step in your research journey? Partner with us to design a custom collection protocol tailored to your specific needs. Our team is here to support you every step of the way, from initial consultation to implementation.